© Niklas Bildhauer , CC BY-SA 2.0 letter / January, 2018 Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome. View in MDC Repository View in PubMed Authors V. Wais L. Kündgen S.R. Bohl S. von Harsdorf R.F. Schlenk K. Döhner V. Teleanu L. Bullinger T.M. Nguyen K. Drognitz J.C. Moulin M. Binnenhei M. Bentz H. Döhner D. Bunjes F. Kuchenbauer M. Ringhoffer Journal Bone marrow transplantation Citation Bone Marrow Transplant 53 (1): 94-96 DOI doi:10.1038/bmt.2017.211 View in MDC Repository View in PubMed